These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 14641568)

  • 21. Dextromethorphan in the treatment of early myoclonic encephalopathy evolving into migrating partial seizures in infancy.
    Chien YH; Lin MI; Weng WC; Du JC; Lee WT
    J Formos Med Assoc; 2012 May; 111(5):290-4. PubMed ID: 22656400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epilepsy in children.
    Arnold ST; Dodson WE
    Baillieres Clin Neurol; 1996 Dec; 5(4):783-802. PubMed ID: 9068881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Symptomatic epilepsies imitating idiopathic generalized epilepsies.
    Oguni H
    Epilepsia; 2005; 46 Suppl 9():84-90. PubMed ID: 16302880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and tolerability of the ketogenic diet in Dravet syndrome - Comparison with various standard antiepileptic drug regimen.
    Dressler A; Trimmel-Schwahofer P; Reithofer E; Mühlebner A; Gröppel G; Reiter-Fink E; Benninger F; Grassl R; Feucht M
    Epilepsy Res; 2015 Jan; 109():81-9. PubMed ID: 25524846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Classification of the myoclonic epilepsies.
    Leppik IE
    Epilepsia; 2003; 44 Suppl 11():2-6. PubMed ID: 14641565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Late-onset epilepsy with status myoclonicus: a diagnostic and management dilemma.
    Al-Awwad AA; Alsuleiman B; Ng YT
    Neurodiagn J; 2014 Mar; 54(1):22-7. PubMed ID: 24783747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A study on epileptic negative myoclonus in atypical benign partial epilepsy of childhood.
    Yang Z; Liu X; Qin J; Zhang Y; Bao X; Chang X; Wang S; Wu Y; Xiong H
    Brain Dev; 2009 Apr; 31(4):274-81. PubMed ID: 18562140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epilepsy with myoclonic absences: Electroclinical characteristics in a distinctive pediatric epilepsy phenotype.
    Zanzmera P; Menon RN; Karkare K; Soni H; Jagtap S; Radhakrishnan A
    Epilepsy Behav; 2016 Nov; 64(Pt A):242-247. PubMed ID: 27770719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retrospective study of perampanel efficacy and tolerability in myoclonic seizures.
    Gil-López FJ; Montoya J; Falip M; Aparicio J; López-González FJ; Toledano R; Gil-Nagel A; Molins A; García I; Serrano P; Domenech G; Torres F; Donaire A; Carreño M
    Acta Neurol Scand; 2018 Aug; 138(2):122-129. PubMed ID: 29573400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and neuropsychological considerations in a case of unrecognized myoclonic epileptic jerks dramatically controlled by levetiracetam.
    Gentile V; Brunetto D; Leo I; Bonetti S; Verrotti A; Franzoni E
    Neuropediatrics; 2010 Dec; 41(6):270-2. PubMed ID: 21445819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Epileptic encephalopathies in infancy. How do we treat them? Does the aetiology influence the response to treatment?].
    Roldan S
    Rev Neurol; 2017 May; 64(s03):S71-S75. PubMed ID: 28524224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Severe myoclonic epilepsy in infancy (Dravet's syndrome). Its nosological characteristics and therapeutic aspects].
    Nieto Barrera M; Candau Fernandez Mensaque R; Nieto Jiménez M
    Rev Neurol; 2003 Jul 1-15; 37(1):64-8. PubMed ID: 12861512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myoclonic epilepsy in infancy: an electroclinical study and long-term follow-up of 38 patients.
    Caraballo RH; Flesler S; Pasteris MC; Lopez Avaria MF; Fortini S; Vilte C
    Epilepsia; 2013 Sep; 54(9):1605-12. PubMed ID: 23889608
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Severe myoclonic epilepsy of infancy.
    Hurst DL
    Pediatr Neurol; 1987; 3(5):269-72. PubMed ID: 3149471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Zonisamide for progressive myoclonus epilepsy: long-term observations in seven patients.
    Kyllerman M; Ben-Menachem E
    Epilepsy Res; 1998 Jan; 29(2):109-14. PubMed ID: 9477142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The effectiveness of antiepileptic therapy in patients with epileptic syndromes associated with myoclonic seizures].
    Mironov MB; Chebanenko NV; Burd SG; Rubleva YV; Tikhonova OA; Krasilshchikova TM; Zykov VP; Shamalov NA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(4):51-59. PubMed ID: 32490619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utility of high doses of melatonin as adjunctive anticonvulsant therapy in a child with severe myoclonic epilepsy: two years' experience.
    Molina-Carballo A; Muñoz-Hoyos A; Reiter RJ; Sánchez-Forte M; Moreno-Madrid F; Rufo-Campos M; Molina-Font JA; Acuña-Castroviejo D
    J Pineal Res; 1997 Sep; 23(2):97-105. PubMed ID: 9392448
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changing Landscape of Dravet Syndrome Management: An Overview.
    Samanta D
    Neuropediatrics; 2020 Apr; 51(2):135-145. PubMed ID: 32079034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacotherapy for Dravet Syndrome.
    Wallace A; Wirrell E; Kenney-Jung DL
    Paediatr Drugs; 2016 Jun; 18(3):197-208. PubMed ID: 26966048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Levetiracetam in patients with generalised epilepsy and myoclonic seizures: an open label study.
    Labate A; Colosimo E; Gambardella A; Leggio U; Ambrosio R; Quattrone A
    Seizure; 2006 Apr; 15(3):214-8. PubMed ID: 16420982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.